Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
American Journal of Epidemiology|April 30, 2025
Long-term performance of the Gleason score in predicting metastatic and fatal prostate cancerZhike Lin, Konrad H Stopsack, Michelangelo Fiorentino, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 25, 2021
Association of Prediagnostic Blood Metabolomics with Prostate Cancer Defined by ERG or PTEN Molecular SubtypesXiaoshuang Feng, Cindy Ke Zhou, Clary B Clish, et al.
The Prostate|July 21, 2017
Investigating the role of the IGF axis as a predictor of biochemical recurrence in prostate cancer patients post-surgeryKieran J Breen, Amanda O'Neill, Lisa Murphy, et al.
Molecular Cancer Research : MCR|August 5, 2025
Tumor Cholesterol Synthesis, Statin Use, and Lethal Prostate CancerSinead Flanagan, Rosina T Lis, Ying Huang, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLCSarah-Louise Ryan, Sam Beard, Martin P Barr, et al.
International Journal of Cancer|July 19, 2019
Family history of prostate cancer and the incidence of ERG- and phosphatase and tensin homolog-defined prostate cancerDana Hashim, Amparo G Gonzalez-Feliciano, Thomas U Ahearn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 11, 2008
Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patientsRichard J Flavin, Paul C Smyth, Stephen P Finn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2024
ctDNA Dynamics and Mechanisms of Acquired Resistance in Patients Treated with Osimertinib with or without Bevacizumab from the Randomized Phase II ETOP-BOOSTER TrialRoss A Soo, Urania Dafni, Ji-Youn Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2025
Prevalence of Mismatch Repair Deficiency in Primary Prostate Cancer in a Large Prospective CohortCiara S McNevin, Anna Keogh, Mutaz Mohammed Nur, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 5, 2008
Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinomaRichard J Flavin, Paul C Smyth, Alexandros Laios, et al.
Pageof 12